Carlos Henrique Camargo Selected Research

Carlos Henrique Camargo Research Topics

8	Infections 07/2022 - 10/2013
4	Peritonitis 02/2022 - 06/2014
2	Sepsis (Septicemia) 11/2020 - 01/2020
1	Mastitis 07/2022
1	Reinfection 12/2021
1	Tetanus 08/2021
1	Diphtheria 08/2021
1	Whooping Cough (Pertussis) 08/2021
1	Diabetes Mellitus 04/2019
1	Invasive Candidiasis 01/2018
1	Candidemia 01/2018
1	Hemolysis 01/2014
1	Cross Infection (Nosocomial Infection) 10/2013
1	Myotonia Congenita (Thomsen Disease) 06/2003
1	Neuromuscular Diseases (Neuromuscular Disease) 06/2003
1	Motor Neuron Disease (Primary Lateral Sclerosis) 06/2003
1	Muscular Diseases (Myopathy) 06/2003
1	Myalgia 06/2003

3	Carbapenems (Carbapenem Antibiotics)IBA 07/2022 - 11/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 10/2013
2	CoagulaseIBA 02/2021 - 06/2014
2	Polymyxins (Polymyxin)IBA 04/2019 - 12/2014
2	AminoglycosidesIBA 04/2019 - 12/2014
2	Pharmaceutical PreparationsIBA 01/2018 - 10/2013
2	Oxacillin (Prostaphlin)FDA LinkGeneric 06/2014 - 10/2013
1	Virulence Factors (Pathogenicity Factors)IBA 02/2022
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	AntigensIBA 08/2021
1	VaccinesIBA 08/2021
1	5'-N-methylcarboxamideadenosineIBA 02/2021
1	Colistin (Coly-Mycin)FDA Link 01/2020
1	Amikacin (A.M.K)FDA LinkGeneric 04/2019
1	Voriconazole (Vfend)FDA LinkGeneric 01/2018
1	Fluconazole (Zonal)FDA LinkGeneric 01/2018
1	Vancomycin FDA LinkGeneric 06/2014
1	GelatinasesIBA 01/2014
1	Streptomycin (Streptomycin Sulfate)FDA Link 01/2014
1	AMP Deaminase (Myoadenylate Deaminase)IBA 06/2003
1	EnzymesIBA 06/2003